2021 Q1 Form 10-Q Financial Statement

#000156459021021322 Filed on April 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $4.419M $3.518M
YoY Change 25.61% -5.68%
Cost Of Revenue $383.0K $170.0K
YoY Change 125.29% -67.31%
Gross Profit $4.036M $3.348M
YoY Change 20.55% 4.3%
Gross Profit Margin 91.33% 95.17%
Selling, General & Admin $3.089M $2.423M
YoY Change 27.49% 56.32%
% of Gross Profit 76.54% 72.37%
Research & Development $2.396M $2.272M
YoY Change 5.46% 29.09%
% of Gross Profit 59.37% 67.86%
Depreciation & Amortization $177.0K $132.0K
YoY Change 34.09% 20.0%
% of Gross Profit 4.39% 3.94%
Operating Expenses $5.485M $4.695M
YoY Change 16.83% 44.02%
Operating Profit -$1.449M -$1.347M
YoY Change 7.57% 2594.0%
Interest Expense $0.00 $150.0K
YoY Change -100.0% -46.43%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.448M -$1.199M
YoY Change 20.77% -621.3%
Income Tax $0.00 -$139.0K
% Of Pretax Income
Net Earnings -$1.448M -$1.060M
YoY Change 36.6% -560.87%
Net Earnings / Revenue -32.77% -30.13%
Basic Earnings Per Share -$0.07 -$0.05
Diluted Earnings Per Share -$0.07 -$0.05
COMMON SHARES
Basic Shares Outstanding 21.49M 21.52M
Diluted Shares Outstanding 21.49M 21.52M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.00M $46.90M
YoY Change -23.24% -6.94%
Cash & Equivalents $36.04M $46.86M
Short-Term Investments
Other Short-Term Assets $500.0K $300.0K
YoY Change 66.67% -40.0%
Inventory
Prepaid Expenses
Receivables $2.872M $5.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $41.93M $52.40M
YoY Change -19.99% -7.75%
LONG-TERM ASSETS
Property, Plant & Equipment $3.567M $3.900M
YoY Change -8.54% -2.5%
Goodwill $1.651M
YoY Change
Intangibles $1.174M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.790M $4.000M
YoY Change 94.75% -56.04%
TOTAL ASSETS
Total Short-Term Assets $41.93M $52.40M
Total Long-Term Assets $7.790M $4.000M
Total Assets $49.72M $56.40M
YoY Change -11.85% -14.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $504.0K $200.0K
YoY Change 152.0% 0.0%
Accrued Expenses $1.303M $1.200M
YoY Change 8.58% 0.0%
Deferred Revenue $3.417M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.224M $4.000M
YoY Change 30.6% 5.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $0.00
YoY Change -100.0%
Total Long-Term Liabilities $100.0K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.224M $4.000M
Total Long-Term Liabilities $100.0K $0.00
Total Liabilities $5.400M $4.000M
YoY Change 35.0% 2.56%
SHAREHOLDERS EQUITY
Retained Earnings -$52.10M
YoY Change
Common Stock $96.46M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.37M $52.41M
YoY Change
Total Liabilities & Shareholders Equity $49.72M $56.40M
YoY Change -11.85% -14.42%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$1.448M -$1.060M
YoY Change 36.6% -560.87%
Depreciation, Depletion And Amortization $177.0K $132.0K
YoY Change 34.09% 20.0%
Cash From Operating Activities -$2.471M -$549.0K
YoY Change 350.09% -47.71%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $286.0K
YoY Change -100.0% -1530.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$286.0K
YoY Change -100.0% 1330.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -54.00K -50.00K
YoY Change 8.0% -61.54%
NET CHANGE
Cash From Operating Activities -2.471M -549.0K
Cash From Investing Activities 0.000 -286.0K
Cash From Financing Activities -54.00K -50.00K
Net Change In Cash -2.525M -885.0K
YoY Change 185.31% -26.25%
FREE CASH FLOW
Cash From Operating Activities -$2.471M -$549.0K
Capital Expenditures $0.00 $286.0K
Free Cash Flow -$2.471M -$835.0K
YoY Change 195.93% -18.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36040000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38565000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2872000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2285000
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2482000
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2229000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
531000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
582000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
41925000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
43661000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3567000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3701000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1174000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1217000
CY2021Q1 us-gaap Goodwill
Goodwill
1651000
CY2020Q4 us-gaap Goodwill
Goodwill
1651000
CY2021Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
1398000
CY2020Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
1398000
CY2021Q1 us-gaap Assets
Assets
49715000
CY2020Q4 us-gaap Assets
Assets
51628000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
504000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
494000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1303000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1531000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3417000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3843000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5224000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5868000
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
126000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
90000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
215000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
214000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
96246000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
96104000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52096000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50648000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
44365000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
45670000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49715000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51628000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
138000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
138000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21494236
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21378833
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21494236
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21378833
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4419000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3518000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
383000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
170000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2396000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2272000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1652000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1285000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1437000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1138000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
5868000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
4865000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1449000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1347000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
148000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1448000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1199000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-139000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1448000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1060000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21494000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21522000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21494000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21522000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
177000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
197000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
83000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
587000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-548000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
253000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-90000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-51000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
84000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
146000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
28000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-229000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
80000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-389000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-220000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2471000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-549000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
286000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-286000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2525000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-885000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47742000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46857000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
61897000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
50000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-50000
CY2020Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
50000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
52408000
CY2021Q1 awre Shares Surrendered To Pay Taxes Related To Unrestricted Stock Value
SharesSurrenderedToPayTaxesRelatedToUnrestrictedStockValue
54000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
197000
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:20pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:10pt;text-align:justify;margin-bottom:0pt;margin-left:5.39%;text-indent:0%;;font-style:normal;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period.&nbsp;&nbsp;<font style="color:#000000;">The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of intangible assets and goodwill recorded as part of the combinations and valuation allowance for deferred income tax assets.</font> Actual results could differ from those estimates.</p>
CY2021Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2021Q1 awre Minimum Period Of Payment Of Transaction Price In Contract With Customer
MinimumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P30D
CY2021Q1 awre Maximum Period Of Payment Of Transaction Price In Contract With Customer
MaximumPeriodOfPaymentOfTransactionPriceInContractWithCustomer
P60D
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3315000
CY2020Q1 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
183000
CY2021Q1 awre Unbilled Receivables Current Revenue Recognized In Advance Of Billings
UnbilledReceivablesCurrentRevenueRecognizedInAdvanceOfBillings
690000
CY2020Q1 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
273000
CY2021Q1 awre Unbilled Receivables Current Billings
UnbilledReceivablesCurrentBillings
437000
CY2020Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
3225000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2837000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3933000
CY2020Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1148000
CY2021Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
1435000
CY2020Q1 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1368000
CY2021Q1 awre Contract With Customer Liability Revenue Recognized Additions Made During Period
ContractWithCustomerLiabilityRevenueRecognizedAdditionsMadeDuringPeriod
-1825000
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2617000
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3543000
CY2021Q1 awre Percentage Of Remaining Performance Obligations Expected To Be Recognized As Revenue
PercentageOfRemainingPerformanceObligationsExpectedToBeRecognizedAsRevenue
0.75
CY2021Q1 awre Minimum Period Of Remaining Performance Obligations
MinimumPeriodOfRemainingPerformanceObligations
P12M
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1900000
CY2021Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
132000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
176000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
169000
CY2020Q4 awre Finite Lived Intangible Assets Amortization Expense Rolling After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFour
345000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1174000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
197000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 awre Estimated Benefit Amount Federal Tax Refund Receivable
EstimatedBenefitAmountFederalTaxRefundReceivable
1500000

Files In Submission

Name View Source Status
0001564590-21-021322-index-headers.html Edgar Link pending
0001564590-21-021322-index.html Edgar Link pending
0001564590-21-021322.txt Edgar Link pending
0001564590-21-021322-xbrl.zip Edgar Link pending
awre-10q_20210331.htm Edgar Link pending
awre-20210331.xml Edgar Link completed
awre-20210331.xsd Edgar Link pending
awre-20210331_cal.xml Edgar Link unprocessable
awre-20210331_def.xml Edgar Link unprocessable
awre-20210331_lab.xml Edgar Link unprocessable
awre-20210331_pre.xml Edgar Link unprocessable
awre-ex311_8.htm Edgar Link pending
awre-ex312_6.htm Edgar Link pending
awre-ex321_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending